$PG (-0,29 %) out $BLK (+0,53 %) repurchased

My wife is killing me. Dispo welltttttttttttt exhausted, but buy the dip 😂

Google's advertising business defies AI rivals and Trump's tariffs + New Intel boss announces 'painful decisions' + Procter & Gamble lowers forecast + Pepsico cuts profit target due to tariff dispute + Evotec beckons with 75 million dollars from research alliance with Bristol-Myers Squibb

Google's $GOOGL (-1,65 %)Advertising business defies AI rivals and Trump's tariffs

• Google's online advertising business continues to grow - despite competition from new AI rivals.
• In the past quarter, advertising revenue rose by 8.5 percent year-on-year to just under 66.9 billion dollars (58.9 billion euros).
• This was slightly above analysts' expectations.
• The share price rose by 4.6 percent at times in after-hours trading.
• Advertising at Google continues to generate the majority of the parent company Alphabet's revenues.
• The development of the advertising business is being monitored very closely.
• A key question is whether attempts by competitors to use artificial intelligence to display direct answers instead of links will leave a mark on Google's search engine.
• Meanwhile, Google itself is moving in this direction with AI-generated overviews of search queries.
• These "AI overviews" currently reach 1.5 billion users per month, said CEO Sundar Pichai.
• AI is also increasingly being used in another area at Google.
• "Significantly more" than 30 percent of the software code - the millions of lines of program code behind Google services - is now pre-formulated by artificial intelligence and taken over by humans, said Pichai.
• In the past, this was mainly manual work for programmers.
• There was also an unusual factor behind the strong increase in profits: the revaluation of the stake in a company not listed on the stock exchange contributed eight billion dollars, it was said.
• A name was not mentioned - but according to the Bloomberg financial service, this is Elon Musk's space company SpaceX.
• According to the report, the internet company participated in a SpaceX financing round a decade ago.

New Intel boss $INTC (+1,81 %)announces 'painful decisions'

• The new CEO of the crisis-ridden chip company Intel has announced "painful decisions" and the prospect of job cuts just a few weeks after taking office.
• Intel must reduce costs and remove bureaucratic hurdles, said Lip-Bu Tan after the presentation of quarterly figures.
• He emphasized that this would also involve cutting jobs.
• Chief Financial Officer David Zinsner said at the same time that Intel could not yet give any figures on the extent of the job cuts.
• The company also wants to reduce costs in other ways.
• The financial service Bloomberg recently reported that Intel could soon announce the reduction of around a fifth of its jobs.
• The number of Intel employees had already fallen to just under 109,000 by the end of last year from a good 124,000 at the end of September.
• Intel once dominated the semiconductor market, but has been struggling with problems for years.
• Graphics card specialist Nvidia has conquered a leading position, particularly in the business with chips for artificial intelligence.
• Intel is also under greater pressure in its traditional business with PC processors and chips for data centers.
• Intel disappointed investors with its sales forecast for the current quarter.
• The shares fell by a good five percent in after-hours trading.
• Intel forecast revenues of between 11.2 and 12.4 billion dollars for the second quarter. Analysts had expected an average forecast of around 12.8 billion dollars.
• From the investors' point of view, this weighed more heavily than the results of the first quarter, in which Intel exceeded market expectations.
• Sales stagnated at 12.7 billion dollars, while analysts had expected a decline to 12.3 billion dollars on average.
• At the bottom line, the loss of 800 million dollars was twice as high as a year ago.
• However, Intel's adjusted earnings per share of 0.13 dollars clearly exceeded analysts' forecasts of just 0.01 dollars.

Procter & Gamble $PG (-0,29 %)lowers forecast

• The gloomy consumer sentiment and the ongoing trade disputes are making the consumer goods group Procter & Gamble more pessimistic for the current financial year.
• The company lowered its sales and profit forecasts when presenting its figures for the third financial quarter.
• The company announced in Cincinnati on Thursday that revenue in the 2024/25 financial year (as at the end of June) is likely to grow organically by only around two percent.
• Previously, the Group had forecast growth of three to five percent.
• This excludes currency and portfolio effects.
• Adjusted earnings per share are also likely to increase less than expected.
• Procter & Gamble now expects growth of two to four percent instead of five to seven percent.
• CFO Andre Schulten had already reported in February that deliveries to retailers had slowed down - the manager warned at the time that the company could miss its profit forecast.
• He also pointed to a decline in consumption in Asia, Africa and the Middle East, which he attributed to the "anti-Western sentiment" prevailing there.
• Analysts had already expected earnings per share to be below the previous Group forecast, but Procter & Gamble has now cut its profit expectations even more sharply than expected.
• In the third quarter, sales fell by two percent to 19.8 billion US dollars (around 17.4 billion euros), as the company also announced.
• In organic terms, revenue grew slightly by one percent.
• However, this was less than analysts had expected.
• At 3.8 billion dollars, net profit was roughly on a par with the previous year.
• Adjusted earnings per share increased by one percent to 1.54 dollars.

Pepsico $PEP (-0,31 %)cuts profit target due to customs dispute

• The US food company Pepsico expects lower profits than before this year due to the global customs dispute.
• Pepsico announced on Thursday that earnings per share adjusted for special effects (core EPS), excluding currency effects, are likely to remain at around the previous year's level.
• Originally, Pepsico had targeted an increase in the mid-single-digit percentage range.
• Sales, on the other hand, are expected to continue to grow organically in the low single-digit percentage range.
• The tariffs are likely to make supply chains more expensive, complained Pepsico CEO Ramon Laguarta according to the press release.
• Pepsico is trying to counteract the higher costs.
• However, volatility and uncertainty are likely to increase.
• At the same time, consumer sentiment remains weak in many regions - here, too, the outlook is uncertain.
• In the twelve weeks to March 22, Pepsico missed analysts' expectations.
• Sales fell by 1.8 percent to 17.92 billion US dollars (15.74 billion euros) compared to the same period last year.
• Net income attributable to shareholders fell by around ten percent to 1.83 billion dollars.

Evotec $EVT (+2,06 %)will receive 75 million dollars from research alliance with Bristol-Myers Squibb $BMY (+0,57 %)

• For the Hamburg-based drug researcher and developer Evotec, the long-term collaboration with the pharmaceutical company Bristol-Myers Squibb is paying off.
• The Hanseatic company announced on Thursday that it had made significant progress in the field of protein degradation.
• Evotec will therefore now receive a total of 75 million dollars in accordance with the agreement.
• The news was well received on the stock market, with the share price rising by almost four percent in pre-market trading.
• Evotec has been working with Bristol-Myers Squibb since 2018 and extended the partnership in 2022.

Friday: Stock market dates, economic data, quarterly figures

Stock exchange holiday Australia

• ex-dividend of individual stocks
• ENGIE EUR 1.48
• Semperit Holding EUR 0.50
• ABN AMRO Bank 0.75 EUR
• BE Semiconductor Industries EUR 2.18

• Quarterly figures / company dates USA / Asia
• 13:00 Colgate-Palmolive quarterly figures
• 13:45 Abbvie quarterly figures

• Quarterly figures / Company dates Europe
• 07:00 Nordex | Südzucker | Safran | Signify quarterly figures | Holcim Trading Update 1Q
• 07:30 Atoss Software quarterly figures
• 08:00 Yara | Palfinger quarterly figures
• 10:00 Bayer | Continental | Merck KGaA AGM | Holcim Analyst Conference
• 14:00 Nordex Conference Call | Akzo Nobel AGM

• Economic data

08:00 DE: Construction industry, new orders and sales February

08:00 UK: Retail Sales March FORECAST: -0.4% yoy/+1.6% yoy previous: +1.0% yoy/+2.2% yoy

08:45 FR: Business Climate Index April FORECAST: 96 previous: 96

16:00 US: Consumer Sentiment Index Uni Michigan (2nd survey) April FORECAST: 50.8 1st survey: 50.8 PREV: 57.0

16:15 US: Atlantic Council, fireside chat with member of the Monetary Policy Committee of the Bank of England, Greene

19:30 US: IMF and World Bank Spring Meetings, IMF Steering Committee (IMFC) press conference.

Merck warns of tariff consequences

Merck & Company $MRK (+0,14 %) recently informed its investors that it expects a loss of around 200 million euros due to new tariffs. This news was not exactly unexpected, but it is causing concern among investors. The potential impact on the company's future returns could be significant. In particular, the impact of the tariffs could severely impact profitability in certain areas of Merck's business. Investors should follow developments closely and keep a close eye on possible adjustments to the company's strategy. In these turbulent times, it is crucial to stay informed and make the right decisions to protect the portfolio.

Procter & Gamble focuses on expensive products

In the USA, Procter & Gamble $PG (-0,29 %) has developed an exciting new strategy to meet the challenges posed by rising tariffs. The company plans to launch a product line that includes high-priced items such as €380 electric toothbrushes and improved razors. CFO Andre Schulten explained that price increases are a key strategy for the company to offset the financial burden of the government's volatile tariff policies. This approach has already proven successful during the COVID-19 pandemic, when Procter & Gamble was able to maintain its market position despite the economic uncertainties. However, the risks should not be underestimated, as consumer spending in the US is already showing a decline, which could potentially jeopardize sales figures. Nevertheless, Schulten sees a growth opportunity of EUR 5 billion in the USA, provided that more consumers can be won over to the new products. This will show how well the company can overcome the challenges.

Sources:

https://finance.yahoo.com/video/merck-warns-big-tariff-hit-172053404.html

https://finance.yahoo.com/news/p-g-leans-380-electric-163000777.html

The share price of $PG (-0,29 %) fell after the consumer goods giant lowered its sales and profit forecast for the full year due to difficult market conditions and trade tensions.

Earnings: USD 1.54 per share (+0.7%)

Forecast USD 1.53 per share

Sales: USD 19.78 billion (-2.2%)

Forecast: USD 20.22 billion

At just 1%, organic sales growth was well below the expected 2.53%, as sales volumes stagnated and prices rose by 1%.

The results varied from segment to segment: Healthcare (+4%), Personal Care (+3%) and Beauty Care (+2%) recorded growth, while Laundry & Home Care stagnated and Baby, Feminine and Family Care declined by 1%. The gross margin fell to 51% as higher costs offset the price advantages.

The company significantly lowered its forecast for the 2025 financial year:

Earnings per share growth:

2% - 4% instead of 5% - 7%

Organic sales growth:

2% instead of 3% - 5%

Earnings per share:

USD 6.72 - 6.82 instead of USD 6.91 - 7.05

Source: https://www.xtb.com/de/Marktanalysen/Trading-News/procter-gamble-aktien-fallen-nach-senkung-der-jahresprognose

Hello!

I have been actively working on my portfolio since the beginning of this year, my strategy is to go towards dividends and a safe investment in ETF's with ETF's I want to achieve a balanced weighting that is not too American-heavy but also focuses on Europe.

I have a monthly savings plan of €300 which is divided as follows:

50 € $IWDA (-0,31 %)

50 € $EXSA (+0,06 %)

40 € $ZPRG (-0,37 %)

40 € $WQDS (-0,53 %)

20 € $O (+0,08 %)

15 € $VZ (+0,95 %)

15 € $ULVR (+0,27 %)

10 € $JPM (-0,68 %)

10 € $JNJ (+0,03 %)

10 € $PG (-0,29 %)

10 € $ENB (+0,4 %)

10 € $ALV (+0,36 %)

10 € $KO (-0,66 %)

10 € $MCD (-0,39 %)

Please do not pay too much attention to the crypto positions, I will liquidate the Shitcoins in the near future when prices are good and switch to ETFs/shares.

Now to my simple question, what do you think of the portfolio? Is it good for my strategy or do you have any tips?

General Mills $GIS (-1,56 %) (fair-favorable, interesting)

Wal-Mart de Mexico $WALMEX* (+1,45 %) (downtrend - weak peso?)

P&G $PG (-0,29 %)

Costco $COST (-0,52 %)

Church & Dwight $CHD (-0,92 %) (very expensive - silent expansion underway? see German website)

Pepsi $PEP (-0,31 %)

Monster $MNST (-1,28 %)

Coca Consol $COKE (-2,07 %)

Lotus Bakeries $LOTB (-0,61 %)

Mondelez $MDLZ (-1,18 %)

Hershey $HSY (-1,08 %)

Most of them are still "very" expensive in my opinion, despite the current price declines.

I would be interested to know which are your favorites for a long-term investment?